Učitavanje...
Phase 2 Clinical Trial of Intrathecal Topotecan in Children with Refractory Leptomeningeal Leukemia: A Children’s Oncology Group Trial (P9962)
PURPOSE: We performed a phase 2 study in children with recurrent or refractory leptomeningeal leukemia to determine the objective response rate after treatment with intrathecal topotecan. PATIENTS AND METHODS: Patients received age-adjusted intrathecal topotecan (0.4 mg/dose for patients > 3 year...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3242923/ https://ncbi.nlm.nih.gov/pubmed/21910214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23317 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|